| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 46.497 | 36.699 | 29.772 | 35.083 | 23.096 | 25.702 | 2.022 | 0 | 0 | - |
| Total Income - EUR | 46.497 | 36.699 | 29.772 | 35.083 | 23.096 | 25.702 | 2.022 | 0 | 0 | - |
| Total Expenses - EUR | 24.736 | 14.084 | 13.804 | 13.291 | 13.843 | 17.976 | 3.329 | 1.487 | 915 | - |
| Gross Profit/Loss - EUR | 21.761 | 22.615 | 15.968 | 21.792 | 9.253 | 7.725 | -1.308 | -1.487 | -915 | - |
| Net Profit/Loss - EUR | 20.366 | 21.881 | 15.670 | 21.441 | 9.022 | 7.306 | -1.368 | -1.487 | -915 | - |
| Employees | 2 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | - |
Check the financial reports for the company - Biosolutions Expert Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 547 | 342 | 144 | -16 | -15 | -15 | -15 | - |
| Current Assets | 51.773 | 70.522 | 91.083 | 112.201 | 120.666 | 51.655 | 23.814 | 15.393 | 14.610 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 18.352 | 3.364 | 18.850 | 23.984 | 35.127 | 30.516 | 23.705 | 14.288 | 8.703 | - |
| Cash | 33.421 | 67.158 | 72.234 | 88.217 | 85.540 | 21.140 | 109 | 1.105 | 5.907 | - |
| Shareholders Funds | 20.420 | 42.093 | 57.050 | 77.445 | 84.966 | 7.355 | 5.442 | 2.539 | 1.616 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 31.353 | 28.429 | 34.580 | 35.098 | 35.843 | 44.302 | 18.357 | 12.839 | 12.979 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Biosolutions Expert Srl